HALB   $0.01  9.52% Market Closed


Current temperature: 0.00
ST: 0, Cor:

ISIN US4053311092
ceo Mr. William A. Hartman
Website https://halberdcorporation.com
Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.